{"id":533647,"date":"2021-09-02T07:03:57","date_gmt":"2021-09-02T11:03:57","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/ikena-oncology-to-participate-in-september-2021-virtual-investor-conferences\/"},"modified":"2021-09-02T07:03:57","modified_gmt":"2021-09-02T11:03:57","slug":"ikena-oncology-to-participate-in-september-2021-virtual-investor-conferences","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/ikena-oncology-to-participate-in-september-2021-virtual-investor-conferences\/","title":{"rendered":"Ikena Oncology to Participate in September 2021 Virtual Investor Conferences"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">BOSTON, Sept.  02, 2021  (GLOBE NEWSWIRE) &#8212; Ikena Oncology, Inc. (Nasdaq: IKNA), a targeted oncology company focused on developing novel cancer therapies targeting key signaling pathways, today announced that management will participate in the virtual Morgan Stanley 19<sup>th<\/sup> Annual Global Healthcare Conference taking place on September 9-15, 2021, and the H.C. Wainwright 23<sup>rd<\/sup> Annual Global Investment Conference, taking place on September 13-15, 2021.<\/p>\n<p>Details are as follows:<\/p>\n<p>\n        <strong>Conference: Morgan Stanley 19<\/strong><br \/>\n        <sup><br \/>\n          <strong>th<\/strong><br \/>\n        <\/sup><br \/>\n        <strong> Annual Global Healthcare Conference<br \/><\/strong>Fireside Chat: Friday, September 10, 2021, 10:15am EST; live and available for replay\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=WI15ex6XCW0YnmrZFBrwOXLDEfPuWFiRw-T7sg_gCAF8PQWaKAvLHCKI-lZYAFpHqAahoCcoG0aqLDKv43LG35slKyIXMmDxueEKKcj72kAmuQhYjKzZvyoXQXOeNaGkfWcQEMPMiRPtlGeVswe0vA==\" rel=\"nofollow noopener\" target=\"_blank\">Webcast Link<\/a><\/p>\n<p>\n        <strong>Conference: H.C. Wainwright 23<\/strong><br \/>\n        <sup><br \/>\n          <strong>rd<\/strong><br \/>\n        <\/sup><br \/>\n        <strong> Annual Global Investment Conference<\/strong><br \/>\n        <br \/>Date: Monday, September 13, 2021; available for replay\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=WI15ex6XCW0YnmrZFBrwOexBijLoIi3qkkqK6ncQTTRnFvArDlgfvbx6kkhme1VJtg3IaqSYdPrAORHdMOukIhqZAc82-YML9kqr1Mbmh8nbxyO_dcR832DzVPGP9-o8HACxFUybXjCtG1TFuI6e-06hSJfHOmqtHycrmzExYdg=\" rel=\"nofollow noopener\" target=\"_blank\">Webcast Link<\/a><\/p>\n<p align=\"justify\">The presentation webcasts can be accessed by visiting the Investors &amp; Media section of the company\u2019s website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=21lMrWs_iNURCVqBmOTva6S4l8aQhg1nLD0q14v1CmEVnFRekncElFn5yVo04_Ey2I-DN_vuMSXGWTllDROEoLzj19LL1VU1O51DYx7S-WM=\" rel=\"nofollow noopener\" target=\"_blank\">www.ikenaoncology.com<\/a>. The webcast will be archived for a period of 90 days following the conclusion of the live event.<\/p>\n<p>\n        <strong>About Ikena Oncology <\/strong>\n      <\/p>\n<p align=\"justify\">Ikena Oncology is focused on developing novel therapies targeting key signaling pathways that drive the formation and spread of cancer. Ikena is advancing multiple programs that target tumor markers as well as programs targeting the tumor microenvironment. The Company\u2019s lead program, IK-930, is a TEAD inhibitor targeting the Hippo signaling pathway, a pathway that can drive formation and increase survival of tumors and also drives development of resistance to multiple existing therapies. Additional programs include an ERK5 inhibitor program targeting the KRAS signaling pathway and several programs targeting the tumor microenvironment and immune signals, two of which are being developed in collaboration with Bristol Myers Squibb. Ikena\u2019s pipeline is built on targeting genetically defined or biomarker-driven cancers and developing therapies that can serve specific patient populations in need of new therapeutic options. To learn more, visit\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=21lMrWs_iNURCVqBmOTva6S4l8aQhg1nLD0q14v1CmFZ7Se2J1OfsPvCH20-Jtt1PovZ_JBNwJPycXCvyu7WewELrspS6s31mH6ZXPQgUoqIDrNcPfWaxA5imb86YdzI37EKfoZnAnDZzvRWI37I1w6zry_GCV1IeDTZzjRA7BrPFv1Ihs4HDXNNKcaKScV8ccWdgAEd9T-iFqUSM7shPgPmoOdgC8ZDUUz4iR-dPnATAdCWT_LZyuiINeB-wyWOEbuKoRXdT6vcxL5B69cnbg==\" rel=\"nofollow noopener\" target=\"_blank\">www.ikenaoncology.com<\/a>\u00a0or follow us on\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=i8F-mVHq4H3YOYPGpsxzjn-kVrOObH53neOPsgk5PcFgWv7kCJbo0oHaokLANgJ8fwvOoED3sOlpmXrVt7Yk7OQpve20kDQc5OuxK_ZOC8lrHWN2YBjsKUIBtFhSyq9vhbTB291LCVGOAuSbpblEwMdtPsHffk_PMISzh9SVDLPGreJlxX5fo85D4bGUqzzSdPutdALJcdG03UsxIUu6Pw==\" rel=\"nofollow noopener\" target=\"_blank\">Twitter<\/a>\u00a0and\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=kc5ClWJZksskX6EDqwNsCoKh2ZIwHmLHZNkrhPOK6Q6bpfo0p7M1NkNqQPT6rEzYySvrJOVyk7B4k75dPRVPYcIyNHEetRXPEsuUWaFLCK4JG-KMritIb9HE1FyBKcEZquWBi5xcLgUqyt82ihO-35y4dDrIvy0zhYxgw-5TET2ndpgVzQ5da43pgF6kJdknQbIzohJpoIAWKaZu9UBSdSpEi3yNeaOiMyhdQ4wq8pFKCef3uvjHJIWDgT-BHeSE\" rel=\"nofollow noopener\" target=\"_blank\">LinkedIn<\/a>.<\/p>\n<p>\n        <strong>Media Contact:<\/strong><br \/>\n        <br \/>Gwen Schanker<br \/>LifeSci Communications<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=kgNT0wSA5B_LLYHq8AdkpVLylShe08F2m1I68Rokl3JPcuSJxSOExy1jqSLjkzgBlHZGoVLlZBHyqq8FFBCWmpyjKR1Bw59P3M2cx7XoOQkzhViZvLdnJGQmrMp77jlM\" rel=\"nofollow noopener\" target=\"_blank\">gschanker@lifescicomms.com<\/a><\/p>\n<p><strong>Investor Contact:<\/strong><br \/>Rebecca Cohen<br \/>Ikena Oncology<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=fQRNJKf5wWBOL05zFRd6n_YVd8jJn8E8Vg-dX6inVx8MhmfnM_PQ8VFIrEnaqHIh_Lwxd8Q6-yGtuKukod3-QK8tpLAd85jK1GaXBky-pTo=\" rel=\"nofollow noopener\" target=\"_blank\">rcohen@ikenaoncology.com<\/a><\/p>\n<p>\u00a0<\/p>\n<p>      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMxODk1NCM0Mzg1NDc2IzIyMDU4NzY=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/NmY3YjBmYWQtMjljNS00OGRlLThiZTctZjg0ZDYyYjNhMWI0LTEyMTc0Mjk=\/tiny\/Ikena-Oncology-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>BOSTON, Sept. 02, 2021 (GLOBE NEWSWIRE) &#8212; Ikena Oncology, Inc. (Nasdaq: IKNA), a targeted oncology company focused on developing novel cancer therapies targeting key signaling pathways, today announced that management will participate in the virtual Morgan Stanley 19th Annual Global Healthcare Conference taking place on September 9-15, 2021, and the H.C. Wainwright 23rd Annual Global Investment Conference, taking place on September 13-15, 2021. Details are as follows: Conference: Morgan Stanley 19 th Annual Global Healthcare ConferenceFireside Chat: Friday, September 10, 2021, 10:15am EST; live and available for replay\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Webcast Link Conference: H.C. Wainwright 23 rd Annual Global Investment Conference Date: Monday, September 13, 2021; available for replay\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Webcast Link The presentation webcasts can be accessed by visiting the Investors &amp; Media section &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/ikena-oncology-to-participate-in-september-2021-virtual-investor-conferences\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Ikena Oncology to Participate in September 2021 Virtual Investor Conferences&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-533647","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.7 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Ikena Oncology to Participate in September 2021 Virtual Investor Conferences - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/ikena-oncology-to-participate-in-september-2021-virtual-investor-conferences\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Ikena Oncology to Participate in September 2021 Virtual Investor Conferences - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"BOSTON, Sept. 02, 2021 (GLOBE NEWSWIRE) &#8212; Ikena Oncology, Inc. (Nasdaq: IKNA), a targeted oncology company focused on developing novel cancer therapies targeting key signaling pathways, today announced that management will participate in the virtual Morgan Stanley 19th Annual Global Healthcare Conference taking place on September 9-15, 2021, and the H.C. Wainwright 23rd Annual Global Investment Conference, taking place on September 13-15, 2021. Details are as follows: Conference: Morgan Stanley 19 th Annual Global Healthcare ConferenceFireside Chat: Friday, September 10, 2021, 10:15am EST; live and available for replay\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Webcast Link Conference: H.C. Wainwright 23 rd Annual Global Investment Conference Date: Monday, September 13, 2021; available for replay\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Webcast Link The presentation webcasts can be accessed by visiting the Investors &amp; Media section &hellip; Continue reading &quot;Ikena Oncology to Participate in September 2021 Virtual Investor Conferences&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/ikena-oncology-to-participate-in-september-2021-virtual-investor-conferences\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-09-02T11:03:57+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMxODk1NCM0Mzg1NDc2IzIyMDU4NzY=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ikena-oncology-to-participate-in-september-2021-virtual-investor-conferences\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ikena-oncology-to-participate-in-september-2021-virtual-investor-conferences\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Ikena Oncology to Participate in September 2021 Virtual Investor Conferences\",\"datePublished\":\"2021-09-02T11:03:57+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ikena-oncology-to-participate-in-september-2021-virtual-investor-conferences\\\/\"},\"wordCount\":317,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ikena-oncology-to-participate-in-september-2021-virtual-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMxODk1NCM0Mzg1NDc2IzIyMDU4NzY=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ikena-oncology-to-participate-in-september-2021-virtual-investor-conferences\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ikena-oncology-to-participate-in-september-2021-virtual-investor-conferences\\\/\",\"name\":\"Ikena Oncology to Participate in September 2021 Virtual Investor Conferences - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ikena-oncology-to-participate-in-september-2021-virtual-investor-conferences\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ikena-oncology-to-participate-in-september-2021-virtual-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMxODk1NCM0Mzg1NDc2IzIyMDU4NzY=\",\"datePublished\":\"2021-09-02T11:03:57+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ikena-oncology-to-participate-in-september-2021-virtual-investor-conferences\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ikena-oncology-to-participate-in-september-2021-virtual-investor-conferences\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ikena-oncology-to-participate-in-september-2021-virtual-investor-conferences\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMxODk1NCM0Mzg1NDc2IzIyMDU4NzY=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMxODk1NCM0Mzg1NDc2IzIyMDU4NzY=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ikena-oncology-to-participate-in-september-2021-virtual-investor-conferences\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Ikena Oncology to Participate in September 2021 Virtual Investor Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Ikena Oncology to Participate in September 2021 Virtual Investor Conferences - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/ikena-oncology-to-participate-in-september-2021-virtual-investor-conferences\/","og_locale":"en_US","og_type":"article","og_title":"Ikena Oncology to Participate in September 2021 Virtual Investor Conferences - Market Newsdesk","og_description":"BOSTON, Sept. 02, 2021 (GLOBE NEWSWIRE) &#8212; Ikena Oncology, Inc. (Nasdaq: IKNA), a targeted oncology company focused on developing novel cancer therapies targeting key signaling pathways, today announced that management will participate in the virtual Morgan Stanley 19th Annual Global Healthcare Conference taking place on September 9-15, 2021, and the H.C. Wainwright 23rd Annual Global Investment Conference, taking place on September 13-15, 2021. Details are as follows: Conference: Morgan Stanley 19 th Annual Global Healthcare ConferenceFireside Chat: Friday, September 10, 2021, 10:15am EST; live and available for replay\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Webcast Link Conference: H.C. Wainwright 23 rd Annual Global Investment Conference Date: Monday, September 13, 2021; available for replay\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Webcast Link The presentation webcasts can be accessed by visiting the Investors &amp; Media section &hellip; Continue reading \"Ikena Oncology to Participate in September 2021 Virtual Investor Conferences\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/ikena-oncology-to-participate-in-september-2021-virtual-investor-conferences\/","og_site_name":"Market Newsdesk","article_published_time":"2021-09-02T11:03:57+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMxODk1NCM0Mzg1NDc2IzIyMDU4NzY=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ikena-oncology-to-participate-in-september-2021-virtual-investor-conferences\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ikena-oncology-to-participate-in-september-2021-virtual-investor-conferences\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Ikena Oncology to Participate in September 2021 Virtual Investor Conferences","datePublished":"2021-09-02T11:03:57+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ikena-oncology-to-participate-in-september-2021-virtual-investor-conferences\/"},"wordCount":317,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ikena-oncology-to-participate-in-september-2021-virtual-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMxODk1NCM0Mzg1NDc2IzIyMDU4NzY=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ikena-oncology-to-participate-in-september-2021-virtual-investor-conferences\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/ikena-oncology-to-participate-in-september-2021-virtual-investor-conferences\/","name":"Ikena Oncology to Participate in September 2021 Virtual Investor Conferences - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ikena-oncology-to-participate-in-september-2021-virtual-investor-conferences\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ikena-oncology-to-participate-in-september-2021-virtual-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMxODk1NCM0Mzg1NDc2IzIyMDU4NzY=","datePublished":"2021-09-02T11:03:57+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ikena-oncology-to-participate-in-september-2021-virtual-investor-conferences\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/ikena-oncology-to-participate-in-september-2021-virtual-investor-conferences\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ikena-oncology-to-participate-in-september-2021-virtual-investor-conferences\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMxODk1NCM0Mzg1NDc2IzIyMDU4NzY=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMxODk1NCM0Mzg1NDc2IzIyMDU4NzY="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ikena-oncology-to-participate-in-september-2021-virtual-investor-conferences\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Ikena Oncology to Participate in September 2021 Virtual Investor Conferences"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/533647","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=533647"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/533647\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=533647"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=533647"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=533647"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}